Gensol Engineering Limited (BOM:542851)

Orchard Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 25, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	1,786	33,353	13,584	3,242	618	690
Market Cap Growth	-10.06%	145.53%	319.03%	424.83%	-10.52%	-
Enterprise Value	13,068	39,736	13,160	3,292	620	751
Last Close Price	46.45	880.65	370.57	98.80	18.82	21.04
PE Ratio	2.04	56.01	58.15	29.23	19.36	31.28
PS Ratio	0.14	3.46	3.41	2.02	0.97	0.86
PB Ratio	0.30	10.65	6.54	6.97	1.70	2.08
P/TBV Ratio	0.35	13.43	6.82	6.98	1.70	2.09
P/FCF Ratio	-	-	-	-	10.97	-
P/OCF Ratio	-	-	11.81	-	10.56	-
EV/Sales Ratio	1.02	4.13	3.31	2.05	0.97	0.93
EV/EBITDA Ratio	3.63	19.97	19.42	16.02	9.62	17.55
EV/EBIT Ratio	5.00	25.27	22.61	17.08	12.06	25.56
EV/FCF Ratio	-	-	-	-	11.01	-
Debt / Equity Ratio	2.28	4.82	2.88	1.77	0.29	0.39
Debt / EBITDA Ratio	3.81	6.52	7.16	4.01	1.63	3.01
Debt / FCF Ratio	-	-	-	-	1.87	-
Asset Turnover	-	0.57	0.63	1.16	0.89	1.38
Inventory Turnover	-	60.96	8.37	3.59	5.40	-
Quick Ratio	-	0.91	1.93	0.86	1.11	1.05
Current Ratio	-	1.36	2.37	1.93	2.28	2.02
Return on Equity (ROE)	-	20.52%	18.34%	26.84%	9.17%	9.58%
Return on Assets (ROA)	-	5.79%	5.71%	8.68%	4.47%	3.13%
Return on Capital (ROIC)	10.36%	7.48%	7.78%	13.70%	6.91%	5.42%
Return on Capital Employed (ROCE)	-	10.50%	6.70%	14.40%	12.00%	7.00%
Earnings Yield	48.41%	1.79%	1.72%	3.42%	5.17%	3.20%
FCF Yield	-	-17.29%	-12.29%	-31.02%	9.12%	-23.27%
Buyback Yield / Dilution	-5.02%	-4.63%	-9.78%	-0.03%	-16.03%	-16.95%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.